| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $12.2M | -9.8% |
| SG&A Expense | $11.6M | -0.7% |
| Operating Income | -$23.8M | +5.6% |
| Net Income | -$21.8M | +7.2% |
| EPS (Basic) | -$1.27 | +33.5% |
| EPS (Diluted) | -$1.27 | +33.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.8M | -51.5% |
| Short-term Investments | $41.4M | -3.3% |
| Current Assets | $43.7M | -6.8% |
| Total Assets | $45.0M | -7.6% |
| Current Liabilities | $2.1M | +52.8% |
| Total Liabilities | $2.8M | +14.8% |
| Stockholders' Equity | $42.2M | -8.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.8M | +10.7% |
| Capital Expenditures | $37K | +12.1% |
| Investing Cash Flow | $1.3M | +117.0% |
| Financing Cash Flow | $13.6M | -47.1% |
| Free Cash Flow | -$16.9M | +10.7% |